Showing results (1931-1940 of 5,090) with videos related to
Sort By:
Pageof 509
Inorganic Chemistry|March 1, 2013
X-ray absorption spectroscopy of a quantitatively Mo(V) dimethyl sulfoxide reductase speciesM Jake Pushie, Julien J H Cotelesage, Ganna Lyashenko, et al.Journal of the American Medical Informatics Association : JAMIA|March 8, 2013
Web-scale pharmacovigilance: listening to signals from the crowdRyen W White, Nicholas P Tatonetti, Nigam H Shah, et al.Acta Virologica|February 1, 1997
Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infectionM Bystrická, M Petríková, M Zatovicová, et al.The American Journal of Psychiatry|December 1, 1993
Subtypes of self-injurious patients with borderline personality disorderM J Russ, E N Shearin, J F Clarkin, et al.European Thyroid Journal|November 24, 2017
European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADSGilles Russ, Steen J Bonnema, Murat Faik Erdogan, et al.Physics in Medicine and Biology|December 15, 2017
Experimental verification of stopping-power prediction from single- and dual-energy computed tomography in biological tissuesChristian Möhler, Tom Russ, Patrick Wohlfahrt, et al.Clinical Chemistry and Laboratory Medicine|March 24, 2019
Diagnostic accuracy of a fully automated multiplex celiac disease antibody panel for serum and plasmaJeff Terryberry, Jani Tuomi, Subo Perampalam, et al.Environmental Research|March 4, 2019
High phthalate exposure increased urinary concentrations of quinolinic acid, implicated in the pathogenesis of neurological disorders: Is this a potential missing link?Feiby L Nassan, Joshua A Gunn, Melissa M Hill, et al.Journal of Comorbidity|May 20, 2020
Associations between midlife chronic conditions and medication use with anxiety and depression: A cross-sectional analysis of the PREVENT Dementia studyLucy E Stirland, Sarah Gregory, Tom C Russ, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|March 15, 2003
Differences in pharmacokinetics between children and adults--II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modelingDale Hattis, Gary Ginsberg, Bob Sonawane, et al.Pageof 509